Your browser is no longer supported. Please, upgrade your browser.
Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Stats
Total: 79 #1
TickerMFLX [NASD]
CompanyMulti-Fineline Electronix, Inc.
CountryUSA
IndustryPrinted Circuit Boards
Market Cap551.20MEPS (ttm)2.02
P/E11.18EPS this Y118.60%
Forward P/E16.86EPS next Y-3.11%
PEG0.75EPS past 5Y-10.90%
P/S0.81EPS next 5Y15.00%
P/B1.55EPS Q/Q116.00%
Dividend-Sales Q/Q-4.20%
Insider Own1.50%Inst Own36.50%
Insider Trans0.00%Inst Trans1.75%
Short Float8.85%EarningsFeb 04/a
Analyst Recom3.00Target Price23.50
Avg Volume213.43K52W Range12.59 - 26.05
Feb-05-16Downgrade Needham Buy → Hold
Feb-05-16 01:35PMWhy Shares of Multi-Fineline Electronix Inc. Surged Today at Motley Fool
Feb-05-16 11:09AMINVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Multi-Fineline Electronix, Inc. of an Investigation Concerning the Fairness of the Sale of the Company to Suzhou Dongshan Precision Manufacturing Co., Ltd. - MFLX Accesswire
Feb-05-16 10:16AMHere's Why Multi-Fineline Electronix's Stock Is Up Nearly 40%
Feb-05-16 08:27AMMulti-Fineline downgraded by Needham
Feb-04-16 06:25PMMulti-Fineline posts 4Q profit AP
Feb-04-16 05:34PM[$$] China's Suzhou Dongshan Precision to Buy Multi-Fineline Electronix at The Wall Street Journal
Feb-04-16 05:33PMMULTI FINELINE ELECTRONIX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendments to Articles
Feb-04-16 04:30PMMFLEX Announces Fourth Quarter And Full-Year 2015 Financial Results PR Newswire
Feb-04-16 04:28PMMFLEX Enters Into Definitive Merger Agreement To Be Acquired By Suzhou Dongshan Precision Manufacturing Co., Ltd. For $23.95 Per Share PR Newswire
Multi-Fineline Electronix, Inc. engages in the engineering, design, and manufacture of flexible printed circuit boards and related component assemblies for the electronics industry. The company offers integrated flexible printed circuits and component assembly solutions, such as design and application engineering, prototyping, high-volume fabrication, component assembly, and testing. It serves original equipment manufacturer and electronic manufacturing service providers in the electronics industry for a range of applications, including smartphones, tablets, computer/data storage products, portable bar code scanners, personal computers, wearables, and other consumer electronic devices. The company primarily operates in the United States, China, Singapore, Malaysia, Korea, and the United Kingdom. Multi-Fineline Electronix, Inc. was founded in 1984 and is based in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BESNARD CHRISTINEEVP, GC & SecretaryJan 13Option Exercise0.009,413050,356Jan 14 06:37 PM
Jin LeiEVP & MD China OperationsJan 13Option Exercise0.0011,399071,637Jan 14 06:41 PM
LEE THOMASEVP Business DevelopmentJan 13Option Exercise0.0010,350044,362Jan 14 06:44 PM
Meshgin RezaPresident & CEOJan 13Option Exercise0.0033,3810221,962Jan 14 06:47 PM
BESNARD CHRISTINEEVP, GC & SecretaryJan 01Option Exercise0.0012,655047,845Jan 05 04:17 PM
TickerTTMI [NASD]
CompanyTTM Technologies Inc.
CountryUSA
IndustryPrinted Circuit Boards
Market Cap649.30MEPS (ttm)-0.23
P/E-EPS this Y-30.80%
Forward P/E6.06EPS next Y14.04%
PEG-EPS past 5Y10.40%
P/S0.36EPS next 5Y19.90%
P/B0.79EPS Q/Q-122.20%
Dividend-Sales Q/Q88.80%
Insider Own0.30%Inst Own71.40%
Insider Trans-23.30%Inst Trans0.36%
Short Float8.28%EarningsFeb 04/a
Analyst Recom1.70Target Price9.50
Avg Volume477.61K52W Range4.84 - 10.93
Feb-05-16 01:16PMEdited Transcript of TTMI earnings conference call or presentation 4-Feb-16 9:30pm GMT
Feb-04-16 06:03PMTTM posts 4Q profit AP
Feb-04-16 04:08PMTTM TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
Feb-04-16 04:05PMTTM Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2015 Results GlobeNewswire
Feb-04-16 07:07AMQ4 2015 TTM Technologies Inc Earnings Release - After Market Close
Jan-29-16 11:51AM5 Stocks Ready for Breakouts at TheStreet
Jan-28-16 11:26AMTTM Technologies Embarks on a Strategic Human Resources Journey After Acquisition by Implementing a Unified ADP Payroll Solution in North America at noodls
Jan-26-16 03:02PMTTM Technologies Earns Recognition as a John Deere "Partner-level Supplier" at noodls
TTM Technologies, Inc., together with its subsidiaries, provides various printed circuit board (PCB) products and backplane assemblies worldwide. The company offers high density interconnect, conventional, flexible, and rigid-flex PCBs, as well as backplane assemblies and IC substrates. It also offers various services, such as design for manufacturability support during new product introduction stages; PCB layout design; simulation and testing services; quick turnaround production; and drilling and routing services. The company's customers include original equipment manufacturers and electronic manufacturing service providers that primarily serve the networking/communications infrastructure products, smartphones, and touchscreen tablets, as well as aerospace and defense, high-end computing, and industrial/medical industries. TTM Technologies, Inc. was founded in 1978 and is headquartered in Costa Mesa, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ALDER KENTON KDirectorFeb 04Sale5.2739,900210,185118,361Feb 05 02:36 PM
EDMAN THOMAS TPresident and CEOFeb 04Sale5.3218,30097,442182,374Feb 05 02:38 PM
Schull Todd BCFO, EVP, TreasurerFeb 04Sale5.3513,10070,102112,623Feb 05 02:39 PM
Soder Douglas LSee RemarksFeb 04Sale5.3512,60067,430152,146Feb 05 02:40 PM
EDMAN THOMAS TPresident and CEOJan 08Sale5.666,44936,512154,983Jan 11 03:20 PM
TickerCTRL [NASD]
CompanyControl4 Corporation
CountryUSA
IndustryDiversified Electronics
Market Cap189.40MEPS (ttm)0.11
P/E73.45EPS this Y100.00%
Forward P/E13.47EPS next Y43.88%
PEG3.67EPS past 5Y15.50%
P/S1.17EPS next 5Y20.00%
P/B1.65EPS Q/Q-54.50%
Dividend-Sales Q/Q11.50%
Insider Own16.80%Inst Own99.50%
Insider Trans0.00%Inst Trans3.79%
Short Float15.57%EarningsFeb 04/a
Analyst Recom3.00Target Price8.00
Avg Volume189.19K52W Range5.41 - 16.13
Feb-05-16 04:07PMEdited Transcript of CTRL earnings conference call or presentation 4-Feb-16 10:00pm GMT
Feb-04-16 05:25PMControl4 reports 4Q loss AP
Feb-04-16 04:11PMCONTROL4 CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Dispositio
Feb-04-16 04:07PMControl4 Extends Stock Repurchase Program Business Wire
Feb-04-16 04:05PMControl4 Acquires Pakedge Device & Software, a Leader in Advanced Home Networking Business Wire
Feb-04-16 04:05PMControl4 Announces Financial Results for Fourth Quarter and Fiscal Year 2015 Business Wire
Feb-04-16 07:07AMQ4 2015 Control4 Corp Earnings Release - After Market Close
Jan-26-16 07:29AMControl4 Rolls Out New Line of Smart Home Solutions Starting at $600 MSRP at noodls
Jan-26-16 07:05AMControl4 Rolls Out New Line of Smart Home Solutions Starting at $600 MSRP Business Wire
Control4 Corporation provides automation and control solutions for the connected home in the Untied States, Canada, and internationally. The company offers Control4 solution that functions as the operating system of the home, integrating music, video, lighting, temperature, security, communications, and other devices in the home automation market. Its Control4 product line comprises the Control4 home operating system and the associated application software, and software development kits (SDK). The company's software components include Director for monitoring and receiving events; Navigator that displays graphical user interfaces; Composer Express tool that simplifies the set-up process for Control4 home automation installation projects; and Composer Professional Edition, a software application to design, configure, and personalize configuring Control4 home automation system. Its software components also comprise Composer Home Edition and Composer Media Edition, which enable consumers to view and configure their Control4 managed devices; DriverWorks SDK, a SDK to develop and test custom two-way interface drivers to support the integration of a new device or an existing driver; and Navigator SDK and Application SDK to customize and deliver new application functionality. In addition, the company's products and services include controller appliances, interface devices, audio solutions, video solutions, lighting products, thermostats, security products, and communication products. Further, it offers 4Sight, a subscription service that enables 24x7 home monitoring and control from virtually anywhere, remote home programming and support, and instant email alerts based on home events. The company sells its products through direct dealers and distributors. Control4 Corporation was founded in 2003 and is headquartered in Salt Lake City, Utah.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PAISLEY CHRISTOPHER BDirectorJul 21Option Exercise5.8435,193205,62380,272Jul 21 04:09 PM
TickerIMMU [NASD]
CompanyImmunomedics Inc.
CountryUSA
IndustryBiotechnology
Market Cap208.41MEPS (ttm)-0.57
P/E-EPS this Y-21.40%
Forward P/E-EPS next Y35.50%
PEG-EPS past 5Y-24.90%
P/S41.68EPS next 5Y-
P/B-EPS Q/Q-25.00%
Dividend-Sales Q/Q-30.00%
Insider Own3.70%Inst Own42.90%
Insider Trans-0.15%Inst Trans0.12%
Short Float18.54%EarningsFeb 03/a
Analyst Recom2.00Target Price2.00
Avg Volume899.72K52W Range1.50 - 5.05
Feb-07-16 09:29AM9:29 am Immunomedics: FDA grants Breakthrough Therapy Designation for sacituzumab govitecan
Feb-05-16 10:17AMOne Reason Why Immunomedics (IMMU) Stock is Soaring Today at TheStreet
Feb-05-16 09:28AMU.S. Food and Drug Administration (FDA) Grants Breakthrough Therapy Designation to Immunomedics for Sacituzumab Govitecan for the Treatment of Patients With Triple-Negative Breast Cancer GlobeNewswire
Feb-05-16 09:05AMEdited Transcript of IMMU earnings conference call or presentation 4-Feb-16 3:00pm GMT
Feb-03-16 04:43PMImmunomedics reports 2Q loss
Feb-03-16 04:02PMIMMUNOMEDICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Feb-03-16 04:00PMImmunomedics Announces Second Quarter Fiscal 2016 Results and Clinical Program Developments GlobeNewswire
Feb-03-16 07:07AMQ2 2016 Immunomedics Inc Earnings Release - After Market Close
Jan-28-16 09:45AMIMMUNOMEDICS ANNOUNCES CONFERENCE CALL AND WEBCAST FOR SECOND QUARTER FISCAL 2016 FINANCIAL RESULTS at noodls
Immunomedics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases. The company is developing Yttrium-90-labeled clivatuzumab tetraxetan, which is in Phase III registration study used for the treatment of pancreatic cancer. It is also developing antibody-drug conjugate (ADC) products comprising IMMU-132, an ADC that contains SN-38, which is in Phase II trials used for the treatment of patients with metastatic triple-negative breast cancer, and small-cell and non-small-cell lung cancers; IMMU-130, an anti-CEACAM5-SN-38 ADC that is in Phase II trials for the treatment of metastatic colorectal cancer; and epratuzumab, which is in two Phase III clinical trials for the treatment of systemic lupus erythematosus. Its early-stage products include Veltuzumab, a humanized monoclonal antibody targeting CD20 receptors on B lymphocytes for the treatment of non-Hodgkin lymphoma (NHL) and autoimmune diseases; Milatuzumab, a humanized monoclonal antibody targeting tumors that expresses the CD74 antigen, which is in Phase 1 studies; Yttrium-90-Labeled Epratuzumab Tetraxetan, a radiolabeled anti-CD22 investigational product candidate for patients with NHL or acute lymphoblastic leukemia; and IMMU-114, a novel humanized antibody for the treatment of patients with B-cell cancers. The company also provides LeukoScan, a diagnostic imaging product for diagnostic imaging to determine the location and extent of infection/inflammation in bone. In addition, it offers other product candidates for the treatment of solid tumors and hematologic malignancies, as well as other diseases, which are in various stages of clinical and pre-clinical development. The company has a collaboration agreement with Algeta ASA for the development of epratuzumab. Immunomedics, Inc. was founded in 1982 and is headquartered in Morris Plains, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MARKISON BRIAN ADirectorDec 01Option Exercise1.5915,00023,85079,499Dec 04 08:52 PM
Stark Don CDirectorDec 01Option Exercise1.5910,00015,90050,450Dec 04 08:56 PM
Stark Don CDirectorDec 01Sale3.165,10016,09145,350Dec 04 08:56 PM
GOLDENBERG DAVID MCSO & Chairman of the BODJun 15Option Exercise2.16270,050583,0342,725,669Jun 16 05:01 PM
GOLDENBERG DAVID MCSO & Chairman of the BODJun 15Option Exercise1.7570,297123,0203,250,165Jun 16 05:01 PM
TickerSUPN [NASD]
CompanySupernus Pharmaceuticals, Inc.
CountryUSA
IndustryDrugs - Generic
Market Cap593.40MEPS (ttm)0.23
P/E52.74EPS this Y113.40%
Forward P/E15.65EPS next Y301.55%
PEG0.75EPS past 5Y67.00%
P/S4.48EPS next 5Y70.00%
P/B5.39EPS Q/Q-85.50%
Dividend-Sales Q/Q-26.50%
Insider Own1.50%Inst Own86.70%
Insider Trans-38.59%Inst Trans-11.26%
Short Float7.80%EarningsMar 08/a
Analyst Recom1.90Target Price26.14
Avg Volume817.64K52W Range8.32 - 23.30
Jan-21-16 04:15PMSupernus Pharmaceuticals, Inc.: Fading performance but may be making a comeback?
Dec-16-15 02:48PMSupernus Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers
Dec-08-15 01:17PMSUPERNUS PHARMACEUTICALS INC Financials
Dec-07-15 04:31PMSUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Dec-04-15 09:00AMSupernus Announces Distribution of Common Stock by NEA GlobeNewswire
Dec-02-15 04:30PMSupernus to Attend Guggenheim Securities Boston Healthcare Conference GlobeNewswire
Dec-01-15 09:16AMSupernus Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : December 1, 2015
Nov-21-15 04:07PMShould You Buy Supernus Pharmaceuticals Inc (SUPN)? at Insider Monkey
Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. Its marketed products include Oxtellar XR, an extended-release oxcarbazepine and Trokendi XR, an extended-release topiramate, which are neurology products used for the treatment of epilepsy. The company products also comprise SPN-810, a molindone hydrochloride that has completed Phase II clinical trials for the treatment of impulsive aggression in patients with attention deficit hyperactivity disorder (ADHD); and SPN-812, a viloxazine hydrochloride, which has completed Phase IIa clinical trials for the treatment of ADHD. In addition, it is developing SPN-809, a viloxazine hydrochloride as a once-daily product candidate for the treatment of depression. The company markets its products through wholesalers and pharmaceutical distributors. Supernus Pharmaceuticals, Inc. was founded in 2005 and is based in Rockville, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bhatt Padmanabh P.Sr. VP of IP, CSODec 09Sale14.904,68569,80788,068Dec 10 05:17 PM
BARRETT M JAMESDirectorDec 08Sale14.7570,9131,045,9530Dec 08 05:16 PM
Bhatt Padmanabh P.Sr. VP of IP, CSODec 08Sale14.909,553142,34192,753Dec 10 05:17 PM
BARRETT M JAMESDirectorDec 07Sale14.3871,0671,022,19270,913Dec 08 05:16 PM
BARRETT M JAMESDirectorDec 04Sale14.5470,9901,032,152141,980Dec 08 05:16 PM
TickerENVA [NYSE]
CompanyEnova International, Inc.
CountryUSA
IndustryCredit Services
Market Cap214.29MEPS (ttm)1.89
P/E3.42EPS this Y43.20%
Forward P/E4.51EPS next Y14.53%
PEG-EPS past 5Y44.30%
P/S0.32EPS next 5Y-
P/B1.07EPS Q/Q-76.80%
Dividend-Sales Q/Q-19.50%
Insider Own4.00%Inst Own74.10%
Insider Trans3.15%Inst Trans5.51%
Short Float9.32%EarningsFeb 04/a
Analyst Recom2.50Target Price7.75
Avg Volume383.23K52W Range4.64 - 24.65
Feb-05-16Reiterated FBR Capital Mkt Perform $13 → $6.50
Feb-05-16 01:54PMEdited Transcript of ENVA earnings conference call or presentation 4-Feb-16 10:00pm GMT
Feb-04-16 06:17PMEnova International posts 4Q profit
Feb-04-16 04:29PMENOVA INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
Feb-04-16 04:16PMEnova Announces Fourth Quarter and Full Year 2015 Results PR Newswire
Feb-04-16 07:07AMQ4 2015 Enova International Inc Earnings Release - After Market Close
Feb-02-16 08:30AM5 Hated Earnings Stocks You Should Love at TheStreet
Jan-29-16 11:53AMEnovas CashEuroNet UK and EuroNetCash Businesses Receive Authorization from the Financial Conduct Authority at noodls
Jan-29-16 11:53AMEnova's CashEuroNet UK and EuroNetCash Businesses Receive Authorization from the Financial Conduct Authority at noodls
Jan-29-16 11:24AMEnova's CashEuroNet UK and EuroNetCash Businesses Receive Authorization from the Financial Conduct Authority PR Newswire
Enova International, Inc. provides online financial services to alternative credit consumers in the United States, the United Kingdom, Australia, Canada, Brazil, and China. It offers short-term consumer loans, installment loans, and line of credit accounts under the CashNetUSA, NetCredit, Headway Capital, QuickQuid, QuickQuid FlexCredit, Pounds to Pocket, OnStride Financial, DollarsDirect, Simplic, and YouXinYi brands. The company is headquartered in Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CASH AMERICA INTERNATIONAL INC10% OwnerFeb 02Sale5.1816,75386,781471,218Feb 03 05:06 PM
CASH AMERICA INTERNATIONAL INC10% OwnerJan 20Sale5.265572,930518,138Jan 21 04:10 PM
Salters James CodyVice President, OperationsDec 21Buy6.184,00024,71810,721Dec 22 08:00 PM
Gray James ADirectorNov 20Buy7.405,00036,99473,566Nov 23 06:14 PM
Gray James ADirectorNov 19Buy7.7917,000132,43068,566Nov 23 06:14 PM
TickerLXU [NYSE]
CompanyLSB Industries Inc.
CountryUSA
IndustryChemicals - Major Diversified
Market Cap142.27MEPS (ttm)-1.15
P/E-EPS this Y-64.50%
Forward P/E-EPS next Y75.70%
PEG-EPS past 5Y-3.10%
P/S0.20EPS next 5Y10.00%
P/B0.35EPS Q/Q-770.60%
Dividend-Sales Q/Q-7.80%
Insider Own2.80%Inst Own86.50%
Insider Trans0.08%Inst Trans3.37%
Short Float12.48%EarningsFeb 26/b
Analyst Recom1.70Target Price16.80
Avg Volume942.56K52W Range3.68 - 47.33
Jan-22-16 01:50PMGE Signs Steam Turbine Power Generating Deals in China
Jan-21-16 03:47PMLSB INDUSTRIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Jan-21-16 01:00PM3M to Sell Pressurized Polyurethane Foam Assets to ICP
Jan-20-16 06:30AMLSB Industries, Inc. Announces That Its Pryor, Oklahoma Facility Resumes Production Business Wire
Jan-18-16 04:45PMGE Healthcare's Omnyx to Offer Digitalized Cancer Diagnosis
Jan-08-16 06:03AMLSB INDUSTRIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Jan-07-16 05:10PMLSB INDUSTRIES INC Files SEC form 8-K/A, Change in Directors or Principal Officers
Dec-30-15 06:30AMLSB Industries, Inc. Provides Update on the Status of Its Cherokee, Alabama and Pryor, Oklahoma Facilities Business Wire
LSB Industries, Inc., through its subsidiaries, manufactures and sells chemical products, water source and geothermal heat pumps, and air handling products. The company operates in two segments, Chemical Business and Climate Control Business. The Chemical Business segment manufactures and sells nitrogen-based chemical products, including anhydrous ammonia, fertilizer grade ammonium nitrate (AN), urea ammonium nitrate, and AN ammonia solution for agricultural applications; high purity and commercial grade anhydrous ammonia, high purity AN, sulfuric acids, concentrated nitric acids, blended and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN and solutions for the mining industry. It also offers blended and regular nitric acid; and industrial and high purity ammonia for various specialty applications, including the reduction of air emissions from power plants. This segment sells its products primarily to the polyurethane, paper, fibers, emission control, and electronics industries, as well as to farmers, ranchers, fertilizer dealers, and distributors. The Climate Control Business segment manufactures and sells a range of heating, ventilation, and air conditioning products that include water source and geothermal heat pumps; hydronic fan coils; large custom air handlers; modular geothermal and other chillers; and other related products for use in commercial/institutional and residential new building constructions, renovation of existing buildings, and replacement of existing systems. This segment sells its products principally to mechanical contractors, original equipment manufacturers, contractors, independent sales representatives, and distributors. The company also sells industrial machinery and related components to machine tool dealers and end users. LSB Industries, Inc. was founded in 1968 and is based in Oklahoma City, Oklahoma.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TEPPER MICHAEL DAWESr. VP-Int'l OperationsDec 01Sale7.062,50017,65029,500Dec 03 12:11 PM
BEHRMAN MARK TEVP and CFOAug 11Buy25.153,00075,4504,000Aug 11 02:49 PM
ADAMS MICHAEL GVP-Financial PlanningJun 26Option Exercise7.863,57528,10018,000Jun 29 04:59 PM
Murdy William FDirectorJun 22Buy41.2050020,6001,500Jun 22 03:37 PM
BENHAM WEBSTER L IIIDirectorJun 01Buy41.472008,2941,200Jun 02 04:38 PM
TickerAOI [NYSE]
CompanyAlliance One International, Inc.
CountryUSA
IndustryTobacco Products, Other
Market Cap102.48MEPS (ttm)-2.22
P/E-EPS this Y82.30%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-17.40%
P/S0.05EPS next 5Y-
P/B0.48EPS Q/Q-21.70%
Dividend-Sales Q/Q5.90%
Insider Own2.50%Inst Own70.50%
Insider Trans0.00%Inst Trans6.37%
Short Float1.15%EarningsFeb 08
Analyst Recom2.00Target Price6.00
Avg Volume47.12K52W Range8.30 - 26.47
Feb-05-16 08:00AMAlliance One International Inc Investor Update Call scheduled for 8:00 am ET today
Feb-05-16 06:11AMALLIANCE ONE INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition
Feb-04-16 05:37PMAlliance One International Announces Investor Information and Arrangements for Call PR Newswire
Jan-28-16 04:37PMALLIANCE ONE INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Dec-08-15 01:13PMALLIANCE ONE INTERNATIONAL, INC. Financials
Nov-29-15 01:16AMDo Hedge Funds Love Control4 Corp (CTRL)? at Insider Monkey
Nov-26-15 06:39AMIs Denison Mines Corp (USA) (DNN) A Good Stock To Buy? at Insider Monkey
Nov-23-15 04:32PMALLIANCE ONE INTERNATIONAL, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Ru
Nov-09-15 09:03AMAlliance One International Inc. Investigated For Potential Securities Law Violations By Block & Leviton LLP PR Newswire
Nov-09-15 08:12AMALLIANCE ONE INTERNATIONAL, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Alliance One International, Inc. purchases, processes, packs, stores, and ships leaf tobacco for manufacturers of cigarettes and other consumer tobacco products worldwide. It operates through South America, Value Added Services, and Other Regions segments. The company is involved in processing and selling flue-cured, burley, and oriental tobaccos, which are used in international brand cigarettes. It also provides agronomy services for growing leaf tobacco. The company was founded in 1904 and is headquartered in Morrisville, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Eckmann Jeffrey ADirectorJun 29Buy22.3750011,1867,300Jul 01 03:01 PM
Eckmann Jeffrey ADirectorMar 30Buy1.1225,00028,00062,200Mar 31 02:53 PM
Kayes Graham JEVP - BRM & LeafMar 30Buy1.1630,00034,80061,073Mar 31 02:52 PM
GREEN C RICHARD JRDirectorMar 30Buy1.105,0005,50015,000Mar 31 02:51 PM
TickerEYEG [NASD]
CompanyEyegate Pharmaceuticals, Inc.
CountryUSA
IndustryBiotechnology
Market Cap24.90MEPS (ttm)-3.72
P/E-EPS this Y55.00%
Forward P/E-EPS next Y65.80%
PEG-EPS past 5Y0.00%
P/S-EPS next 5Y-
P/B2.69EPS Q/Q-480.00%
Dividend-Sales Q/Q-
Insider Own2.30%Inst Own67.00%
Insider Trans-Inst Trans0.27%
Short Float0.57%EarningsNov 12
Analyst Recom2.00Target Price9.00
Avg Volume230.41K52W Range1.38 - 27.00
Feb-03-16 09:40AMInsider Alert: Here's Why These Small Caps Could Be Ready To Rally Accesswire
Feb-02-16 10:22AM4 Stocks That are Making Big Moves Early Today Accesswire
Feb-01-16 07:07AMCoverage initiated on Eyegate Pharmaceuticals by Rodman & Renshaw
Jan-26-16 04:23PMEYEGATE PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
Jan-19-16 08:30AMEyeGate Pharma Enrolls First Patient in Confirmatory Phase 3 Clinical Trial EGP-437-006 for Non-Infectious Anterior Uveitis GlobeNewswire
Jan-19-16 06:05AMEYEGATE PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jan-14-16 09:49AMEyegate Pharmaceuticals to Present at the Noble Financial Capital Markets 12th Annual Investor Conference GlobeNewswire
Dec-08-15 01:18PMEYEGATE PHARMACEUTICALS INC Financials
Nov-12-15 02:41PMWhy are These Five Stocks Deep in Green Territory on Thursday? at Insider Monkey
Nov-12-15 08:30AMEyeGate Reports Third Quarter 2015 Financial Results and Provides Business Update GlobeNewswire
Eyegate Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapeutics and drug delivery systems for treating eye diseases. The company is developing EGP-437 that has completed Phase III clinical trials for the treatment of non-infectious anterior uveitis, a form of intraocular inflammation of the anterior portion of the uvea. It is also developing Eyegate II drug delivery system. Eyegate Pharmaceuticals, Inc. is based in Waltham, Massachusetts.
TickerFCTY [NASD]
Company1st Century Bancshares, Inc.
CountryUSA
IndustryRegional - Pacific Banks
Market Cap91.94MEPS (ttm)0.23
P/E38.70EPS this Y-68.40%
Forward P/E18.54EPS next Y77.78%
PEG-EPS past 5Y17.90%
P/S4.10EPS next 5Y-
P/B1.34EPS Q/Q50.00%
Dividend-Sales Q/Q27.10%
Insider Own2.70%Inst Own23.70%
Insider Trans0.00%Inst Trans0.53%
Short Float0.04%EarningsMar 03/a
Analyst Recom3.00Target Price8.00
Avg Volume2.87K52W Range5.48 - 9.00
Jan-05-16 04:18PM1st Century Bancshares, Inc. (California): Strong price momentum but will it sustain?
Dec-08-15 01:17PM1ST CENTURY BANCSHARES, INC. Financials
Nov-05-15 07:20PM1ST CENTURY BANCSHARES, INC. Files SEC form 10-Q, Quarterly Report
Oct-28-15 03:39PM1st Century posts 3Q profit
Oct-28-15 03:25PM1ST CENTURY BANCSHARES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
Sep-25-15 11:35AM1st Century Bancshares Files for IPO
Sep-15-15 12:01PM1st Century Bancshares, Inc. (California) Earnings Q2, 2015
Aug-06-15 06:20PM1ST CENTURY BANCSHARES, INC. Files SEC form 10-Q, Quarterly Report
1st Century Bancshares, Inc. operates as a bank holding company for 1st Century Bank, National Association that provides a range of banking services. Its deposits products include business and personal checking, money market, attorney-client trust, and trust accounts, as well as certificates of deposits. The company also offers loans consisting of business and personal lines of credit and term loans; tenant improvement and equipment financing; bridge and/or specific purpose loans; commercial, industrial, multi-family, and 1-4 single family residential real estate loans; and personal home equity loans and lines of credit. In addition, it provides cash management services; debit and credit cards; and online banking services. The company serves family owned businesses and their employees, professional service firms, real estate professionals and investors, small and medium-sized businesses, and high net worth individuals, as well as the legal, accounting, and medical professions. It operates a branch office and a private banking center in Los Angeles, as well as relationship offices in Santa Monica and Beverly Hills, California. The company was founded in 2003 and is headquartered in Los Angeles, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROTHENBERG ALAN ICEO and Chairman of the BoardJun 18Option Exercise8.01307,5732,463,6601,052,616Jun 19 04:48 PM
1 2 3 4 5 6 7 8 next